PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Aug-2021 Amcor reaches major company milestone since Bemis acquisition Amcor
12-Aug-2021 Flow Neuroscience receives Series A funding to make self-managed medical device available globally. Five global investors back revolutionary depression treatment Flow Neuroscience
12-Aug-2021 Almac Group and PILA PHARMA Ink Manufacturing Agreement Almac Sciences
12-Aug-2021 Hardman & Co Research: Real Estate Credit Investments (RECI): Experience shows resilience of the model Hardman & Co Research
12-Aug-2021 Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy Terumo Blood and Cell Technologies
12-Aug-2021 Medigene AG: Medigene provides Q2 update and 6M report 2020 Medigene AG
12-Aug-2021 Defence Therapeutics Inc.: DEFENCE THERAPEUTICS RECEIVES DTC ELIGIBILITY Defence Therapeutics Inc.
12-Aug-2021 ​​​​​​​Eckert & Ziegler with Strong First Half of 2021 Eckert & Ziegler Strahlen- und Medizintechnik AG
12-Aug-2021 Medios AG continues on record course after strong growth in first half of 2021 Medios AG
12-Aug-2021 SYNLAB delivers outstanding financial and operational results in Q2 and H1 2021 SYNLAB AG
12-Aug-2021 Biotest AG: Biotest increases sales by 10% in the first half of 2021 Biotest AG
12-Aug-2021 Straumann Group further accelerates growth in the second quarter to deliver record first half-year result Straumann Holding AG
11-Aug-2021 HAEMATO AG announces preliminary figures for Q2 2021: Increase in Q2 revenue by 41% and EBIT by 596% compared to the same quarter last year. HAEMATO AG
11-Aug-2021 Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow’s Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma Industry Bristol Myers Squibb
11-Aug-2021 Sensyne Health to conduct its first multi-omics AI drug discovery project in partnership with Oxford University Sensyne Health
11-Aug-2021 DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients DFE Pharma
11-Aug-2021 ViewMind announces developer agreement with HP to help revolutionise the diagnosis and treatment of cognitive disorders ViewMind
11-Aug-2021 Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone Mission Therapeutics
11-Aug-2021 ASLAN PHARMACEUTICALS REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE ASLAN PHARMACEUTICALS
11-Aug-2021 NICE RECOMMENDS KITE’S TECARTUS®▼ FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA (MCL) AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY INCLUDING A BRUTON’S TYROSINE KINASE (BTK) INHIBITOR IN ENGLAND WITHIN THE CANCER DRUGS FUND Kite